| Financial Year |
March 31 2023 |
| Monetary Funds |
5,661,225,258.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
220,268,030.83 |
| Advances to Suppliers |
22,197,955.23 |
| Other Receivables |
7,124,121.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
229,891,607.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
382,623,455.14 |
| Total Current Assets |
6,523,330,428.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
268,121,580.51 |
| Investment Properties |
25,812,826.56 |
| Fixed Assetes |
28,301,545,730.18 |
| Under-construction Projects |
4,357,977,048.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
833,809,935.74 |
| R&D expenses |
2,134,192.18 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
320,167,962.96 |
| Deferred Income Tax Assets |
165,455,378.30 |
| Other Non-Current Assets |
433,748,026.67 |
| Sub-Total of Non-Current Assets |
34,941,799,411.31 |
| Total Assets |
41,465,129,839.76 |
| Short-Term Loans |
150,128,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
408,248,795.11 |
| Accounts Payable |
1,108,489,588.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
67,950,266.75 |
| Taxes Payable |
187,839,051.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
129,318,646.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
810,781,171.41 |
| Other Current Liabilities |
3,579,857.60 |
| Sub-Total of Current Liabilities |
2,869,026,360.47 |
| Long-term Loans |
10,914,117,052.68 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,282,722,180.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
97,903,318.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,717,106,613.95 |
| Total Liabilities |
17,586,132,974.42 |
| Paid-In Capital(Or Share Stock) |
3,196,005,805.00 |
| Capital Surplus |
11,135,190,956.07 |
| Surplus Reserve |
259,794,696.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,698,244,998.59 |
| Minority Stockholder's Interest |
3,566,017,654.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,312,979,210.35 |
| Owner's Equity（Stockholder's Equity） |
23,878,996,865.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
41,465,129,839.76 |
